Meeting Banner
Abstract #3704

Establishing a Dose-Response Relationship for Lithium-Induced Modulation of [1-13C]Pyruvate Metabolism in the Heart

Jonas Steinhauser1, Patrick Wespi1, Grzegorz Kwiatkowski1, and Sebastian Kozerke1

1Institute for Biomedical Engineering, ETH and University Zurich, Zürich, Switzerland

Lithium is the first-line drug used in bipolar disorder, a chronic widespread psychiatric disease. Lithium is a narrow therapeutic index drug and shows cardiac side effects. The present work demonstrates the detectability of lithium induced changes of mitochondrial metabolism in cardiomyocytes using hyperpolarized [1-13C]pyruvate magnetic resonance imaging of the in-vivo rat heart. Metabolic and functional response to lithium was examined for different lithium plasma concentrations.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords